BackRayzeBio Overview

RayzeBio Total Current Liabilities

Latest total current liabilities for RYZB: $17M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$17.11M

Peer average / median

Loading

RayzeBio Total Current Liabilities History

Loading

RayzeBio vs. peers: Total Current Liabilities Comparison

Loading

RayzeBio Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RayzeBio (RYZB) FAQ

The latest total current liabilities for RYZB is $17M as of September 2023. Investors often review this figure alongside RayzeBio's historical trend and sector peers before judging valuation or financial health.

A total current liabilities figure of $17M for RYZB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RYZB's total current liabilities ($17M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.